Comparison of Health Canada and the Patented Medicine Prices Review Board and/or Prescrire International on a drug-by-drug level, all drugs
| Patented Medicine Prices Review Board/Prescrire International | ||
|---|---|---|
| Innovative | Not innovative | |
| Health Canada | ||
| Priority review | 33 | 58 |
| Standard review | 19 | 235 |
Positive predictive value=36.3% (95% CI 26.6% to 47.1%).
Negative predictive value=92.5% (95% CI 88.4% to 95.3%).